Skip to main content
Home
Member Login RDCRN Network Site

Header Social Media

  • Our Research
    • Diseases Studied
    • Research Studies
    • Clinical Sites
    • Research Publications
    • Prior Research
  • Patients and Families
    • Patient Advocacy Groups
    • Resources for Patients and Families
    • Glossary
  • Researchers and Clinicians
    • Funding Opportunities
    • Lectures
  • Early Stage Investigators
    • Funding Opportunities
    • Pilot and Feasibility Grants
    • Scholar Awards
    • Meet Our Early Stage Investigators
  • News and Events
    • Latest News
  • About Us
    • Our Consortium
    • Meet Our Team
    • Goals, Mission & Vision
    • Frequently Asked Questions
    • Contact Us
An NIH-Funded Rare Diseases Clinical Research Network Consortium

Latest News

Congenital Disorders of Glycosylation Over Time: What We’re Learning from a Natural History Study

To learn more about the development and outcomes of congenital disorders of glycosylation (CDG), the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) is conducting a natural history study, “Clinical and Basic Investigations into CDG.” The team is exploring the progression of CDG, clinical symptoms, and how they vary among different population groups.

Read More
Congenital Disorders of Glycosylation Over Time: What We’re Learning from a Natural History Study

Training Program for Clinical Research in Rare Disease Launches New Session

November 9, 2022

Read More
Screenshot from a presentation on the Rare Diseases Research R25 Curriculum Grant

Patient Spotlight: Franklin and List Families Navigate Life with Congenital Disorder of Glycosylation

June 30, 2022

Read More
The Franklin family at a playground, and Dee List wearing a graduation cap

Rare Research Report: December 2022

December 5, 2022

Read More
Rare Research Report logo

Senior Researcher Spotlight: Kent Lai Develops Gene-Based Therapeutics for Congenital Disorders of Glycosylation

June 21, 2022

Read More
Kent Lai, PhD, sitting in a chair in his lab

Early Stage Investigator Spotlight: Steven Sloan Develops Brain Organoids to Study Congenital Disorders of Glycosylation

June 14, 2022

Read More
Headshot of Steven Sloan, MD, PhD

RDCRN Research Roundup: June 2022

June 1, 2022

Read More
Rare Diseases Clinical Research Network logo with text: Research Roundup, #RDCRN

Rare Disease Research Challenges, Opportunities Due to COVID-19 Featured in New Article

May 4, 2021

Read More
rare-disease-neuro-special-report

New Genetic Marker Identified for Congenital Disorders of Glycosylation

July 8, 2021

Read More
The Frontiers in Congenital Disorders of Glycosylation (FCDGC) logo appears over a gray graphic of molecules
  • Load More
Tweets by FrontierCDG

Footer menu

  • Web Policies
  • Rare Diseases Clinical Research Network
  • Genetic and Rare Diseases Information Center
  • Members Login
  • Contact Us

The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). FCDGC is funded under grant number U54NS115198 as a collaboration between NCATS, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Office of Dietary Supplements (ODS). This website is hosted by the network's Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the FCDGC administrative coordinating center at Mayo Clinic, Rochester and does not necessarily represent the official views of the NIH. 

social media